Title: Bisi JE, et al. Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression. Mol Cancer Ther. 2016 May;15(5):783-93.
1977495-97-8
1374639-75-4
1211441-98-3
1211443-80-9
1374639-79-8
1328934-40-2